Skip to main content
SpringerLink
Log in

Biologic markers, cellular differentiation, and metastatic head and neck cancer

  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Summary

The plateau in survival rates from head and neck cancer as well as the increasing incidence of disease among various populations demands the need for new perspectives in head and neck oncology. In pursuit of that goal, investigators have been developing improved biologic markers for metastatic risk of head and neck cancer. Such markers can be placed into categorical groupings, of which markers for cellular differentiation may be the most relevant. Among the growth factors relevant to head and neck cancer, epidermal growth factor and its receptor have received the most attention. Those tumors with unregulated growth factor control tend towards a more dedifferentiated state. Additionally, the degree of cellular differentiation and resulting risk of metastases may be predetermined in an individual through constitutively expressed susceptibility genes. Polymorphisms of the L-myc oncogene identified within peripheral blood lymphocytes may represent such a marker. Certain polymorphisms of this gene will identify individuals likely to express dedifferentiated head and neck cancer. Finally, the expression of cell-surface differentiation antigens may govern the capacity of cell-mediated host immune systems to control metastatic growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arthur K, Farr HW (1972) Prognostic significance of histologic grade in epidermoid carcinoma of the mouth and pharynx. Am J Surg 124:489–492

    Google Scholar 

  2. Byrne M (1991) Prognostic value of various molecular and cellular features in oral squamous cell carcinomas: a review. J Oral Pathol Med 20:413–420

    Google Scholar 

  3. Byrne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E (1989) New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 18:432–437

    Google Scholar 

  4. Byrne M, Thrane PS, Dabelsteen E (1991) Loss of expression of blood group antigen H is associated with cellular invasion and spread of oral squamous cell carcinomas. Cancer 67:613–618

    Google Scholar 

  5. Cancers of the oral cavity and pharynx: a statistics review monograph 1973–1987 (1990) U.S. Department of Health and Human Services Monograph

  6. Esteban F, Concha A, Delagdo M, Perez-Ayala M, Ruiz-Cabello, Garrido F (1990) Lack of MHC class 1 antigens and tumor aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer 62:1047–1051

    Google Scholar 

  7. Esteban F, Concha A, Huelin C, Perez-Ayala M, Pedrinance S, Ruiz-Cabello F, Garrido F (1989) Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx. Int J Cancer 43:436–442

    Google Scholar 

  8. German J (ed) (1983) Chromosome mutation and neoplasia. Liss, New York

    Google Scholar 

  9. Hsu TC, Johnston DA, Cherry LM, Ramkisson D, Schantz SP, Jessup JM, Winn RD, Shirley L, Furlong C (1989) Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 43:403–409

    Google Scholar 

  10. Jakobsson PA, Enneroth CM, Killander PD, Moberger G, Martensson B (1973) Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol 12:1–8

    Google Scholar 

  11. Karre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H-2 deficient lymphoma variants suggest alternative immune defense strategy. Nature 319:675–678

    CAS  PubMed  Google Scholar 

  12. Kumagai S, Kojima S, Nozaki S, Imai K, Nakagawa K, Yamamoto E (1992) Immunohistologic distribution of basement membrane in oral squamous cell carcinoma. Proceedings of the Third International Conference on Head and Neck Cancer, p 78

  13. Michales L (1987) Ear nose and throat histopathology. Springer, New York Berlin Heidelberg, p 387

    Google Scholar 

  14. Mickel RA, Kessler DJ, Taylor JMG, Lichtenstein A (1988) Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients. Cancer Res 48:5017–5022

    Google Scholar 

  15. Ozawa S, Ueda M, Ando N, Shimizu N, Abe O (1989) Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas. Cancer 63:2169–2173

    Google Scholar 

  16. Pfeiffer D, Stellwag B, Pfeiffer A, Borlinghaus P, Meier W, Schiedel P (1989) Clinical implications of epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol Oncol 33:146–150

    Google Scholar 

  17. Platz H, Fires R, Hudec M, Min TJPA, Wagner R (1983) The prognostic relevance of various factors at the time of the first admission of the patient. Retrospective study on carcinoma of the oral cavity. J Maxillofac Surg 11:3–12

    Google Scholar 

  18. Roland NJ, Castin AW, Nash J, Stell PM (1992) Value of grading squamous cell carcinoma of the head and neck. Head Neck 14:224–229

    Google Scholar 

  19. Ross W, Fabbro D, Kung W, Costa SD, Eppenberger U (1986) Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells. Proc Natl Acad Sci USA 88:991–995

    Google Scholar 

  20. Sakr WA, Zarbo RJ, Jabobs JR, Crissman JD (1987) Distribution of basement membrane in squamous cell carcinoma of the head and neck. Hum Pathol 18:1043–1050

    Google Scholar 

  21. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi V, Deo MG (1989) Restriction fragment length polymorphism of the L-myc gene in oral cancer patients. Br J Cancer 61:530–533

    Google Scholar 

  22. Scambia G, Panici PB, Battaglia F, Mancusa S (1990) Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors. Cancer 67:1347–1351

    Google Scholar 

  23. Schantz SP, Gullamondegui OM (1988) Developing perspectives in head and neck tumor immunology. Probl Gen Surg 5:99–112

    Google Scholar 

  24. Schantz SP, Ordonez NG (1991) Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer. Nat Immun Cell Growth Regul 10:278–288

    CAS  PubMed  Google Scholar 

  25. Schantz SP, Shillitoe JJ, Brown B (1985) Natural killer cell activity and head and neck cancer: a clinical assessment. J Natl Cancer Inst 77:869–875

    Google Scholar 

  26. Schantz SP, Dimery I, Lippman S, Layman GL, Pellegrina C, Morice R (1992) A phase II study of interleukin-2 and interferon-alpha against head and neck cancer. Invest New Drugs 10:223

    Google Scholar 

  27. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W (1991) E-cadherin expression in squamous cell carcinomas of the head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51:6328–6337

    Google Scholar 

  28. Trinchieri G, Perussia B (1984) Human natural killer cells: biologic pathologic aspects. Lab Invest 50:489–513

    Google Scholar 

  29. UICC (1987) TNM classification of malignant tumors, 4th edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  30. Wolf GT, Carey TE, Schantz SP, McClatchey KD, Poore J, Glaser L, Hayadisha DJS, Hsu S (1990) Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. J Natl Cancer Inst 82:1566–1572

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Head and Neck Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, 10021, New York, NY, USA

    S. P. Schantz

Authors
  1. S. P. Schantz
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Based on a presentation at the International Symposium on the N0 neck: Göttingen, September 1992

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schantz, S.P. Biologic markers, cellular differentiation, and metastatic head and neck cancer. Eur Arch Otorhinolaryngol 250, 424–428 (1993). https://doi.org/10.1007/BF00181082

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00181082

Key words

Search

Navigation